AlgoDAO is partnering with Humanode, the first crypto-biometric network on Algorand

AlgoDAO
AlgoDAO
Published in
2 min readDec 16, 2022

Hey, Pilots!

The AGF (AlgoDAO Governance Framework) revealed a roadmap powered by NFT-gated Governance through Discord. Today, we are announcing the enhancement of this NFT-centric system with the biometric technology of Humanode.

We are thrilled to announce that AlgoDAO partnered with Humanode to use their innovative technology to make these NFTs not only unique but truly ‘yours’.

Humanode is the first crypto-biometric network that uses biometric technology to provide Sybil resistance and revolutionary governance models to the crypto industry.

1 human = 1 node = 1 vote

The project was built as an EVM-compatible Substrate Chain that enables NFT projects, DAOs, GameFi, metaverse, and other Dapps to integrate unique online identities through the use of a direct biometric authentication system.

Over 10,000 unique human validators have joined the network and major projects like Republic, Ink.Finance, Aikon, and Aragon, among others, have partnered with them as well.

Furthermore, Humanode is backed by Republic Capital, Tribe Capital, Wintermute, Blizzard, Polygon founders and others.

AlgoDAO & Humanode partnership

Today, we are happy to present AlgoDAO’s Governance NFTs, which will be enhanced by Humanode technology: they will have unique traits based on the hash resulting from the bioauth process of Humanode. As a result, you’ll be the real owner of a unique NFT.

This is the first step of a wider partnership with Humanode. We are confident its Sybil-resistant technology will find manifold applications in the Algorand DeFi and Web3 ecosystem!

Furthermore, our team is delighted to work with Humanode on a cross-marketing plan, as well as participate in AMAs and other social media events.

We are really excited to take another significant step in transforming AlgoDAO into a fully decentralized DAO! Keep an eye on our social channels for updates and other developments news.

--

--